Purpose
To investigate the effects of long-term acebutolol, a beta-blocker with mild intrinsic sympathomimetic activity, in the prevention
of late death in high-risk patients surviving AMI
References
Boissel J-P, Leizorovicz A, Picolet H, et al: Secondary prevention after high-risk acute myocardial infarction with
low-dose acebutolol. Am J Cardiol 1990, 66:251–260.
|
Farmacêutica